Neogen (NEOG) Depreciation & Amortization (CF) (2010 - 2026)
Neogen (NEOG) recorded quarterly Depreciation & Amortization (CF) of $26.5 million in Q1 2026, up 691.75% quarter-over-quarter from $3.3 million in Q4 2025, and up 3.11% on a YoY basis from $25.7 million in Q1 2025.
Neogen (NEOG) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Neogen's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $26.5 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 3.11% year-over-year to $26.5 million; the TTM figure through Feb 2026 stood at $89.2 million (up 0.79% YoY), while the FY2025 annual figure was $119.5 million, up 2.37% from the prior year.
- Depreciation & Amortization (CF) was $26.5 million for Q1 2026 at Neogen, up from $3.3 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $30.3 million in Q2 2025 to a low of $3.3 million in Q4 2025.
- Historically, Depreciation & Amortization (CF) has averaged $21.5 million across 5 years, with a median of $27.5 million in 2023.
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) soared 401.55% in 2023, then tumbled 86.02% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $26.7 million in 2022, then gained by 10.21% to $29.5 million in 2023, then sank by 86.02% to $4.1 million in 2024, then decreased by 18.76% to $3.3 million in 2025, then soared by 691.75% to $26.5 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $26.5 million (Q1 2026), $3.3 million (Q4 2025), and $29.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Neogen | 2.03 Bn | 1.87 Bn | 99.00 Mn | 26.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 26.50 Mn |
| Feb 28, 2026 | 26.50 Mn |
| Nov 30, 2025 | 3.35 Mn |
| Nov 30, 2025 | 3.35 Mn |
| Aug 31, 2025 | 29.06 Mn |
| Aug 31, 2025 | 29.06 Mn |
| May 31, 2025 | 30.28 Mn |
| May 31, 2025 | 30.28 Mn |
| Feb 28, 2025 | 25.70 Mn |
| Feb 28, 2025 | 25.70 Mn |
| Nov 30, 2024 | 4.12 Mn |
| Nov 30, 2024 | 4.12 Mn |
| Aug 31, 2024 | 29.80 Mn |
| Aug 31, 2024 | 29.80 Mn |
| May 31, 2024 | 28.86 Mn |
| May 31, 2024 | 28.86 Mn |
| Feb 29, 2024 | 29.65 Mn |
| Feb 29, 2024 | 29.65 Mn |
| Nov 30, 2023 | 29.47 Mn |
| Nov 30, 2023 | 29.47 Mn |